Michaela Witzling

7% Hypertonic Saline in Acute Bronchiolitis: A Randomized Controlled Trial

Hypertonic saline or high volume normal saline for viral bronchiolitis: Mechanisms and rationale

Dexamethasone inhalations in RSV bronchiolitis: A double‐blind, placebo‐controlled study

Pharmacotherapy of impaired mucociliary clearance in non‐CF pediatric lung disease. A review of the literature

Association between Common Toll‐Like Receptor 4 Mutations and Severe Respiratory Syncytial Virus Disease

Hypertonic (3%) saline Vs 0.9% saline nebulization for acute viral bronchiolitis: A randomized controlled trial

Airway Mucus Function and Dysfunction

Nebulized hypertonic saline solution for acute bronchiolitis in infants

Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis

Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses

Nebulised hypertonic saline solution for acute bronchiolitis in infants

Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease

Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis

Nebulized Hypertonic Saline for Bronchiolitis

Bronchodilators for bronchiolitis

Evaluation of an Alternative Chest Physiotherapy Method in Infants With Respiratory Syncytial Virus Bronchiolitis

Nebulized Hypertonic Saline for Bronchiolitis in the Emergency Department

Nebulized Hypertonic Saline Without Adjunctive Bronchodilators for Children With Bronchiolitis

Nebulized 3% Hypertonic Saline Solution Treatment in Hospitalized Infants With Viral Bronchiolitis*

Nebulized 3% Hypertonic Saline Solution Treatment in Ambulatory Children with Viral Bronchiolitis Decreases Symptoms